Aurora B kinase: a potential drug target for cancer therapy

Azaj Ahmed, Anas Shamsi, Taj Mohammad, Gulam Mustafa Hasan, Asimul Islam, Md Imtaiyaz Hassan

Research output: Contribution to journalReview articlepeer-review

27 Scopus citations

Abstract

Background: Ensuring genetic integrity is essential during the cell cycle to avoid aneuploidy, one of the underlying causes of malignancies. Aurora kinases are serine/threonine kinase that play a vital role in maintaining the genomic integrity of the cells. There are three forms of aurora kinases in the mammalian cells, which are highly conserved and act together with several other proteins to control chromosome alignment and its equal distribution to daughter cells in mitosis and meiosis. Methods: We provide here a detailed analysis of Aurora B kinase (ABK) in terms of its expression, structure, function, disease association and potential therapeutic implications. Results: ABK plays an instrumental in mitotic entry, chromosome condensation, spindle assembly, cytokinesis, and abscission. Small-molecule inhibitors of ABK are designed and synthesized to control cancer progression. A detailed understanding of ABK pathophysiology in different cancers is of great significance in designing and developing effective therapeutic strategies. Conclusion: In this review, we have discussed the physiological significance of ABK followed by its role in cancer progression. We further highlighted available small-molecule inhibitors to control the tumor proliferation and their mechanistic insights.

Original languageEnglish
Pages (from-to)2187-2198
Number of pages12
JournalJournal of Cancer Research and Clinical Oncology
Volume147
Issue number8
DOIs
StatePublished - Aug 2021

Keywords

  • Aneuploidy
  • Aurora kinase
  • Cancer therapeutics
  • Cell cycle regulation
  • Small molecule inhibitors

Fingerprint

Dive into the research topics of 'Aurora B kinase: a potential drug target for cancer therapy'. Together they form a unique fingerprint.

Cite this